Skip Navigation


IJE Advance Access originally published online on March 2, 2005
International Journal of Epidemiology 2005 34(2):482-483; doi:10.1093/ije/dyh211
This Article
Right arrow Extract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
34/2/482    most recent
dyh211v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Tokudome, S.
Right arrow Articles by Moore, M. A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tokudome, S.
Right arrow Articles by Moore, M. A
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Published by Oxford University Press on behalf of the International Epidemiological Association

Letters to the Editor

Black tea and cardiovascular disease

Shinkan Tokudome1,*, Imaeda Nahomi2, Chiho Goto3, Yuko Tokudome3 and Malcolm A Moore4

1 Department of Health Promotion and Preventive Medicine, Nagoya City University Graduate School of Medical Sciences, Mizuho-ku, Nagoya, Japan
2 Medical Welfare Center Kouseiin, Meito-ku, Nagoya, Japan
3 Nagoya Bunri University, Inazawa, Japan
4 Division of Experimental Pathology and Chemotherapy, National Cancer Center, Research Institute, Chuo-ku, Tokyo, Japan

* Corresponding author. Department of Health Promotion and Preventive Medicine, Nagoya City University Graduate School of Medical Sciences, Mizuho-ku, Nagoya 467-8601, Japan. E-mail: tokudome{at}med.nagoya-cu.ac.jp

Dr Sesso et al.1 could not detect a significant association between black tea consumption and risk of cardiovascular disease using well-established cohorts for the study on health and physical activity. Dr Poole et al.2 have commented on the paper with regard to the concept of causation. We would like to add another view based on nutritional epidemiology and biological pathogenesis.

Potential protective effects of black tea against cardiovascular disease and cancer are attributed to polyhenol compounds and flavonoids/flavonols, including catechin/EGCG and theaflavin. The authors admit that they lacked a data-based approach3 for selecting foods/beverages contributory to certain nutrients in order to assess intake of flavonols/theaflavins from black tea.

We can assume from the literature4 that black tea is a major source of catechin/EGCG, but comparisons within several cups of black tea may not have enough power to detect any favourable effects of catechin/EGCG. In other words, a dose–response relationship could not be proven even after taking into account confounding coffee consumption. Although thus far inconsistent, some beneficial effects have been experienced with large intakes of black/green tea, such as ≥10 cups/day.5–8 We need a wide range of comparisons for cups of black tea to evaluate possible protective effects, if any, on cardiovascular disease.

The concentrations of catechin/EGCG in black tea are rather less than in green tea.4 In addition, antioxidant activity of black tea scored by oxygen radical absorbing capacity (ORAC) is lower than that for green tea. Furthermore, flavenoids are supplied to a greater extent by vegetables and fruit than several cups of black tea. Thus the authors should, at least, adjust for effects of consumption of vegetables and fruit.

Finally, it is known that folate is antiangiogenic because it is a cofactor in the metabolism of homocysteine to methionine. According to our recent study,9 folate is supplied by green tea along with vegetables and fruit; however, its content in black tea is far less than in green tea. Black tea thus seems generally less anticarcinogenic, antimutagenic, and antiangiogenic than green tea. Moreover, any fluids/beverages, including water, black/green tea, and coffee, may be important in terms of blood viscosity and excretion/dilution of mutagenic and carcinogenic substances.10,11


    References
 Top
 References
 
1 Sesso HD, Paffenbarger Jr RS, Oguma Y, Lee I-M. Lack of association between tea and cardiovascular disease in college alumni. Int J Epidemiol 2003; 32:527–33.[Abstract/Free Full Text]

2 Poole C, Peters U, Il'yasova D, Arab L. Commentary: this study falied. Int J Epidemiol 2003; 32:534–35.[Free Full Text]

3 Willett W. Nutritional Epidemiology. 2nd Edn. Monograph in Epidemiology and Biostatistics, Vol. 30. New York, Oxford University Press, 1998.

4 Henning SM, Fajardo-Lira C, Lee HW, Youssefian AA, Go VLW, Heber D. Catechin content of 18 teas and a green tea extract supplement correlates with the antioxidant capacity. Nutr Cancer 2003; 45:226–35.[CrossRef][Web of Science][Medline]

5 Kono S, Ikeda M, Tokudome S, Kuratsune M. A case-control study of gastric cancer and diet in northern Kyushu, Japan. Jpn J Cancer Res 1988; 79:1067–74.[CrossRef][Web of Science][Medline]

6 Yu GP, Hsieh CC, Wang LY, Yu SZ, Li XL, Jin TH. Green-tea consumption and risk of stomach cancer: a population-based case-control study in Shanghai, China. Cancer Causes Control 1995; 6:532–38.[CrossRef][Web of Science][Medline]

7 Imai K, Suga K, Nakachi K. Cancer-preventive effects of drinking green tea among a Japanese population. Prev Med 1997; 26:769–75.[CrossRef][Web of Science][Medline]

8 Peters U, Poole C, Arab L. Does tea affect cardiovascular disease? A meta-analysis. Am J Epidemiol 2001; 154:495–503.[Abstract/Free Full Text]

9 Imaeda N, Goto C, Tokudome Y, Ikeda M, Maki S, Tokudome S. Folate intake and food sources in Japanese female dietitians. Environ Health Prev Med 2002; 7:156–61.[CrossRef]

10 Chan J, Knutsen SF, Blix GG, Lee JW, Frase GE. Water, other fluids, and fatal coronary heart disease: the Adventist Health Study. Am J Epidemiol 2002; 155:827–33.[Abstract/Free Full Text]

11 Moore MA. Awash with alcohol in the world of prevention. Asian Pacific J. Cancer Prev 2000; 1:91–93.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Int J EpidemiolHome page
C. Poole, U. Peters, D. Il'yasova, and L. Arab
Authors' response
Int. J. Epidemiol., April 1, 2005; 34(2): 483 - 483.
[Full Text] [PDF]


This Article
Right arrow Extract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
34/2/482    most recent
dyh211v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Tokudome, S.
Right arrow Articles by Moore, M. A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tokudome, S.
Right arrow Articles by Moore, M. A
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?